1-9 of 9
influenza with pneumonia
Close
Sort by
Journal Articles

Two Year Update of Phase II Trial of Pembrolizumab, Lenalidomide and Dexamethasone As Post -Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma

Meena Bansal, DO, David S. Siegel, Jaeil Ahn, PhD, Rena Feinman, PhD, David H. Vesole, MD PhD, Joshua R Richter, MD, Andrew L. Pecora, MD, Elli Gourna Paleoudis, PhD, Scott D. Rowley, MD, Michele L. Donato, MD, Robert Korngold, PhD, Palka Anand, RN, BSN, CCRP, Laura McBride, RN, BSN, OCN, Kristin Ivanovski, RN, BSN, CCRP, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1911.
https://doi.org/10.1182/blood-2019-125155
Published: 2019
Journal Articles

Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Richard J Lin, MD PhD, Stephanie M Lobaugh, MS, Martina Pennisi, Jason T Chan, RN, Yakup Batlevi, PhD, Josel D Ruiz, MPH, Theresa A Elko, MS, Molly A. Maloy, MS, Connie Lee Batlevi, MD PhD, Parastoo B. Dahi, MD, Sergio A Giralt, MD, Elena Mead, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Bianca Santomasso, MD PhD, Craig S. Sauter, MD, Michael Scordo, MD, Gunjan L. Shah, MD, Beatriz Korc-Grodzicki, MD PhD, Soo Jung Kim, NP, Mari Lynne Silverberg, Chelsea A Brooklyn, Sean M. Devlin, PhD, Miguel-Angel Perales, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1603.
https://doi.org/10.1182/blood-2019-125162
Published: 2019
Journal Articles

A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone As Post Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma

Noa Biran, MD, Tracy Andrews, PhD, Rena Feinman, PhD, David H. Vesole, MD PhD, Joshua R Richter, MD, Joshua Zenreich, Palka Anand, RN, BSN, CCRP, Laura McBride, RN, BSN, OCN, Kristin Ivanovski, RN, BSN, CCRP, Robert Korngold, PhD, David Siegel, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1831.
https://doi.org/10.1182/blood.V130.Suppl_1.1831.1831
Published: 2017
Journal Articles

Hyperhaemolysis in Sickle Cell Disease Is Not Necessarily a Transfusion Reaction

Elizabeth A Jones, MB ChB MRCPCH FRCPath, Louise Smith, RCN MSc, Russell D Keenan, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2015) 126 (23): 4595.
https://doi.org/10.1182/blood.V126.23.4595.4595
Published: 2015
Journal Articles

Phase 1 Study Of The Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib (Car) In Patients With Relapsed and/Or Refractory Multiple Myeloma (RRMM)

Jatin J. Shah, M.D., Lei Feng, M.S., Sheeba K. Thomas, M.D., Donna M. Weber, M.D., Michael Wang, MD, Brandi Hilder, Raymond Alexanian, M.D., Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1982.
https://doi.org/10.1182/blood.V122.21.1982.1982
Published: 2013
Journal Articles

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Jatin J. Shah, M.D., Donna M. Weber, M.D., Sheeba K. Thomas, MD, Raymond Alexanian, M.D., Michael Wang, M.D., Muzaffar H. Qazilbash, MD, Simrit Parmar, M.D., Nina Shah, MD, Qaiser Bashir, MD, Uday R. Popat, M.D., Brandi Hilder, Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 4082.
https://doi.org/10.1182/blood.V120.21.4082.4082
Published: 2012
Journal Articles

Sirolimus/Tacrolimus Facilitates Preferential Recovery of Regulatory T Cells (Treg) After Allogeneic Hematopoietic Cell Transplantation (HCT), and Is More Effective Than Methotrexate/Tacrolimus in Preventing Grade II-IV Acute Graft Vs. Host Disease (GVHD) and Moderate to Severe Chronic Gvhd

Joseph Pidala, MD, MS, Jongphil Kim, PhD, Heather Jim, PhD, Hugo F. Fernandez, MD, Marcie Tomblyn, MD, MS, Mohamed A Kharfan-Dabaja, MD, Brian C. Betts, MD, Taiga Nishihori, MD, Mian Xu, William E. Janssen, PhD, Frederick L Locke, MD, Ernesto Ayala, MD, Lia Perez, MD, Janelle Perkins, PharmD, Teresa Field, MD, PhD, Leonel Ochoa, Melissa Alsina, MD, Claudio Anasetti, MD
Journal: Blood
Blood (2011) 118 (21): 323.
https://doi.org/10.1182/blood.V118.21.323.323
Published: 2011
Journal Articles

A Reduced Capacity To Generate Activated Protein C and the Role of PAI-1 Deficiency on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia.

Tymen Keller, Matthijs van Wissen, Koen van der Sluijs, PhD, Eric van Gorp, PhD, Joost Meijers, PhD, Tom van der Poll, PhD, Harry Buller, PhD, Dees Brandjes, PhD, Marcel Levi, PhD, Victor Gerdes, PhD
Journal: Blood
Blood (2005) 106 (11): 2134.
https://doi.org/10.1182/blood.V106.11.2134.2134
Published: 2005
Journal Articles

Combination Therapy with Rituximab and Fludarabine in Waldenstrom’s Macroglobulinemia.

Steven P. Treon, Andrew Branagan, Parveen Wasi, Christos A. Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Sari Heitner Enschede, Eva Kimby
Journal: Blood
Blood (2004) 104 (11): 753.
https://doi.org/10.1182/blood.V104.11.753.753
Published: 2004